[{"NetIncomeLoss_2_Q2_USD":11248000.0,"DividendsCommonStockCash_2_Q2_USD":4110000.0,"ProceedsFromMinorityShareholders_2_Q2_USD":0.0,"GoodwillImpairmentLoss_1_Q2_USD":0.0,"GoodwillImpairmentLoss_2_Q2_USD":1859000.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q2_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_2_Q2_USD":1000.0,"ProceedsFromDivestitureOfBusinesses_2_Q2_USD":674000.0,"IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets_2_Q2_USD":-283000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":14968000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-18079000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q2_USD":10288000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":51325000.0,"GainLossOnSaleOfPropertyPlantEquipment_2_Q2_USD":-429000.0,"InterestAndOtherIncome_1_Q2_USD":4000.0,"InterestAndOtherIncome_2_Q2_USD":47000.0,"AccountsAndOtherReceivablesNetCurrent_0_Q2_USD":9983000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":12843000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":12820000.0,"InterestPaidNet_2_Q2_USD":944000.0,"CommonStockDividendsPerShareDeclared_1_Q2_USD":0.0,"AssetsCurrent_0_Q2_USD":92139000.0,"LongTermDebtCurrent_0_Q2_USD":4635000.0,"StockholdersEquityOther_1_Q2_USD":-38000.0,"StockholdersEquityOther_2_Q2_USD":-81000.0,"Assets_0_Q2_USD":585018000.0,"CommonStockSharesIssued_0_Q2_shares":15057859.0,"IncomeTaxesPaidNet_2_Q2_USD":57000.0,"FurnitureAndFixturesGross_0_Q2_USD":55914000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":20565000.0,"TreasuryStockValue_0_Q2_USD":31628000.0,"LongTermDebt_0_Q2_USD":38320000.0,"AccruedInsuranceCurrent_0_Q2_USD":2180000.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_2_Q2_USD":2043000.0,"TreasuryStockShares_0_Q2_shares":2214737.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":9022000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":20699000.0,"RestructuringCharges_1_Q2_USD":94000.0,"RestructuringCharges_2_Q2_USD":1987000.0,"ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesSaleOfInterestByParent_2_Q2_USD":386000.0,"StockRepurchasedDuringPeriodShares_2_Q2_shares":0.0,"MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders_1_Q2_USD":1313000.0,"ShareBasedCompensation_2_Q2_USD":3389000.0,"CommonStockDividendsPerShareDeclared_2_Q2_USD":0.32,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":6853000.0,"ProceedsFromLinesOfCredit_2_Q2_USD":99000000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":4478000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":112000000.0,"GainLossOnSaleOfInterestInProjects_1_Q2_USD":1073000.0,"GainLossOnSaleOfInterestInProjects_2_Q2_USD":1073000.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_0_Q2_USD":0.0,"LongTermNotesPayable_0_Q2_USD":685000.0,"Revenues_1_Q2_USD":83857000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":5333000.0,"Revenues_2_Q2_USD":196574000.0,"NumberOfReportableSegments_2_Q2_Segment":2.0,"IncomeTaxExpenseBenefit_1_Q2_USD":3882000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":4174000.0,"AccountsReceivableNetCurrent_0_Q2_USD":36029000.0,"ConsolidationLessThanWhollyOwnedSubsidiaryParentOwnershipInterestChangesPurchaseOfInterestByParent_2_Q2_USD":0.0,"MinorityInterest_0_Q2_USD":1434000.0,"NumberOfStatesInWhichEntityOperates_0_Q2_State":39.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":97191000.0,"CommonStockValue_0_Q2_USD":151000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":4531000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":-10270000.0,"CostsAndExpenses_1_Q2_USD":64573000.0,"ProvisionForDoubtfulAccounts_2_Q2_USD":2100000.0,"ProvisionForDoubtfulAccounts_1_Q2_USD":739000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_2_Q2_USD":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q2_USD":43000.0,"OperatingLeaseLiability_0_Q2_USD":90832000.0,"LongTermLineOfCredit_0_Q2_USD":33000000.0,"InterestExpenseOnPrepetitionLiabilitiesRecognizedInStatementOfOperations_2_Q2_USD":0.0,"CostsAndExpenses_2_Q2_USD":161599000.0,"Liabilities_0_Q2_USD":191602000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":43555000.0,"OtherAssetsNoncurrent_0_Q2_USD":1591000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":923000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":1713000.0,"GoodwillWrittenOffRelatedToSaleOfBusinessUnit_2_Q2_USD":0.0,"OtherAssetsCurrent_0_Q2_USD":2572000.0,"SharesIssuedPricePerShare_0_Q2_USD":81.02,"PaymentsOfDividendsMinorityInterest_2_Q2_USD":5707000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":61242000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":82965000.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":1987000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":43555000.0,"NonoperatingIncomeExpense_1_Q2_USD":8383000.0,"NonoperatingIncomeExpense_2_Q2_USD":7999000.0,"LiabilitiesCurrent_0_Q2_USD":87353000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":26363000.0,"PaymentsToAcquireProductiveAssets_2_Q2_USD":4628000.0,"LeaseholdImprovementsGross_0_Q2_USD":33631000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":48356000.0,"LongTermDebtNoncurrent_0_Q2_USD":33685000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":1502000.0,"ImpairmentOfLongLivedAssetsToBeDisposedOf_1_Q2_USD":0.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":18645000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":22275000.0,"Goodwill_0_Q2_USD":330894000.0,"PaymentsToAcquireInterestInSubsidiariesAndAffiliates_2_Q2_USD":144000.0,"OtherOperatingActivitiesCashFlowStatement_2_Q2_USD":0.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":67011000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":-8880000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":3389000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":20007000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":3825000.0,"GrossProfit_1_Q2_USD":19284000.0,"NetIncomeLoss_1_Q2_USD":10232000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":22534000.0,"ProceedsFromPaymentsForOtherFinancingActivities_2_Q2_USD":0.0,"NoncashOrPartNoncashAcquisitionPayablesAssumed1_2_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":8930000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":4635000.0,"OperatingLeasePayments_1_Q2_USD":6555000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":54895000.0,"OperatingLeasePayments_2_Q2_USD":14345000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":256688000.0,"AdditionalPaidInCapital_0_Q2_USD":91258000.0,"ShortTermLeaseCost_1_Q2_USD":215000.0,"ShortTermLeaseCost_2_Q2_USD":509000.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-5969000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.032,"PaymentsOfDividendsCommonStock_2_Q2_USD":4110000.0,"GrossProfit_2_Q2_USD":34975000.0,"NumberOfOperatingSegments_2_Q2_Segment":2.0,"LeaseCost_1_Q2_USD":9544000.0,"LeaseCost_2_Q2_USD":19182000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":195473000.0,"OperatingLeaseCost_2_Q2_USD":15627000.0,"DeferredIncomeTaxExpenseBenefit_2_Q2_USD":-1737000.0,"PreferredStockValue_0_Q2_USD":0.0,"AccountsPayableTradeCurrent_0_Q2_USD":1802000.0,"ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates_2_Q2_USD":19000.0,"OperatingIncomeLoss_1_Q2_USD":10262000.0,"OperatingIncomeLoss_2_Q2_USD":14276000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q2_USD":0.0,"OperatingLeaseCost_1_Q2_USD":7815000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":83857000.0,"CommonStockSharesAuthorized_0_Q2_shares":20000000.0,"ProceedsFromSaleOfProductiveAssets_2_Q2_USD":21000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":11633000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":9439000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":6359000.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q2_USD":136728000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"RepaymentsOfNotesPayable_2_Q2_USD":314000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":196574000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":585018000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":16809000.0,"PreferredStockSharesAuthorized_0_Q2_shares":500000.0,"VariableLeaseCost_1_Q2_USD":1514000.0,"VariableLeaseCost_2_Q2_USD":3046000.0,"TaxesPayableCurrent_0_Q2_USD":4637000.0,"IncreaseDecreaseInOtherOperatingLiabilities_2_Q2_USD":345000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":2470000.0,"StockholdersEquity_0_Q2_USD":255254000.0,"GoodwillAcquiredDuringPeriod_2_Q2_USD":13845000.0,"LaborAndRelatedExpense_1_Q2_USD":43429000.0,"LaborAndRelatedExpense_2_Q2_USD":112433000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":392000.0,"ProfitLoss_1_Q2_USD":14763000.0,"ProfitLoss_2_Q2_USD":18101000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":1.19,"EarningsPerShareBasicAndDiluted_1_Q2_USD":0.99,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q2_USD":7535000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":19075000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":29591000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":89545000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":33642000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":15568000.0,"GoodwillPurchaseAccountingAdjustments_2_Q2_USD":1232000.0,"Ticker":"USPH","CIK":"885978","name":"U S PHYSICAL THERAPY INC \/NV","OfficialName":"U.S. Physical Therapy Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1366569153.0","Country":"United States","Sector":"Health Care","Industry":"Medical Specialities","Market":"NYSE","SP500":"nan","filed":"20200807"}]